Supplementary analysis shows improved disease free survival in muscle-invasive bladder cancer cases, highlighting transcriptomic profiles and subtyping models.
Figure S1. Disease Free Survival Outcomes for N = 84 TURBT cases from the ABACUS trial subtyped by Lund (A), Consensus (B) and TCGA (C) subtyping models.
No takes yet. Share an insight, caveat, or question.
Jong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: